Cargando…
The starting line for COVID-19 vaccine development
Autores principales: | Lee, Nelson, McGeer, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255757/ https://www.ncbi.nlm.nih.gov/pubmed/32473680 http://dx.doi.org/10.1016/S0140-6736(20)31239-3 |
Ejemplares similares
-
A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination
por: Boretti, Alberto
Publicado: (2021) -
Universal coronavirus vaccines: the time to start is now
por: Giurgea, Luca T., et al.
Publicado: (2020) -
Age and frailty in COVID-19 vaccine development
por: Andrew, Melissa K, et al.
Publicado: (2021) -
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Publicado: (2021) -
Developing COVID-19 vaccine policy in increments
por: Saag, Michael S
Publicado: (2021)